SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-108561
Filing Date
2023-04-21
Accepted
2023-04-20 18:20:55
Documents
2
Group Members
PROSIGHT FUND, LPPROSIGHT PARTNERS, LLCPROSIGHT PLUS FUND, LPW. LAWRENCE HAWKINS

Document Format Files

Seq Description Document Type Size
1 SC 13G d465958dsc13g.htm SC 13G 104061
2 EX-99.1 d465958dex991.htm EX-99.1 12697
  Complete submission text file 0001193125-23-108561.txt   118412
Mailing Address 5956 SHERRY LANE SUITE 1365 DALLAS TX 75225
Business Address 5956 SHERRY LANE SUITE 1365 DALLAS TX 75225 214-468-0008
Prosight Management, LP (Filed by) CIK: 0001617201 (see all company filings)

IRS No.: 263706721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Subject) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90539 | Film No.: 23834138
SIC: 2834 Pharmaceutical Preparations